Telangana DCA busts quack practicing allopathy without MBBS in Nagarkurnool
The DCA team seized nearly 20 varieties of medicines, including higher generation antibiotics, anti-ulcer drugs, analgesics etc, worth Rs 10,000, which were illegally stocked without a drug license for sale at the clinic
Published Date - 26 September 2024, 02:59 PM
Hyderabad: The drug inspectors from Drugs Control Administration (DCA), Telangana raided the premises of a quack, Vasantpur Ravikumar, who was practicing allopathy without MBBS qualification in a clinic at Velgonda Village, Bijinapalle mandal, Nagarkurnool district.
During the course of the raids, the DCA team seized nearly 20 varieties of medicines, including higher generation antibiotics, anti-ulcer drugs, analgesics etc, worth Rs 10,000, which were illegally stocked without a drug license for sale at the clinic.
The raids were conducted by S. Viswanth Reddy, Drugs Inspector, Nagarkurnool and S. Vinay, Drugs Inspector, Narayanpet along with other officers.
The DG, TSDCA, V B Kamalasan Reddy wholesalers/dealers who supply medicines to such unqualified persons are also punishable under the Drugs and Cosmetics Act, and stringent action shall be taken against such Wholesalers/Dealers.
In another raid, the DCA teams have detected drugs falsely manufactured and sold under the guise of food products or nutraceuticals. The DCA teams detected Ferin-XT tablets (Ferrous Ascorbate, Folic Acid and Zinc Tablets) that were circulating in the market in Hyderabad. The tablets were falsely manufactured under a ‘food license (FSSAI license)’, DCA said.
The tablets were found to be illegally manufactured at Twins Pharma, S.V.Nagar, Mallapur, as a food product/nutraceutical. As per the label claim of the product, it is classified as a ‘drug’ according to the Drugs and Cosmetics Act.
The product ‘Ferin-XT Tablets’ must be manufactured only under a ‘drug license’ issued under the Drugs and Cosmetics Act, adhering strictly to the ‘Good Manufacturing Practices’ (GMP) outlined in Schedule-M of the Drugs Rules. Additionally, it must meet the quality standards prescribed in the ‘Indian Pharmacopoeia’ (IP) as mandated, DG, DCA, V B Kamalasan Reddy said.